Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bar Harbor BioTechnology develops genetic diagnostic tests and research tools for gene expression analysis. The company has launched a diagnostic division focused on genetic risk assessment testing, with initial development on colorectal cancer genetic risk assessment tests in collaboration with Clinical Reference Laboratory.[1][9] The company also maintains a research tools business using its StellARray platform for qPCR-based analysis.[5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bar Harbor BioTechnology.